Comparison of long occlusive femoropopliteal de novo versus previous endovascularly treated lesions managed with in situ saphenous bypass
Copyright © 2022 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved..
BACKGROUND: The aim of this study was to compare the 2-year outcomes of de novo versus postendovascular lesion treatment of femoropopliteal occlusions included in a national, multicenter, observational, prospective registry based on the treatment of critical Limb-threatening IschaeMia with infragenicular Bypass adopting in situ SAphenous VEin technique (LIMBSAVE) registry.
METHODS: From January 2018 to December 2019, 541 patients from 43 centers have been enrolled in the LIMBSAVE registry. Of these patients, 460 were included in the present study: 341 (74.1%) with de novo lesions (DN group) and 119 (25.9%) with postendovascular treatment lesions (PE group). Initial outcome measures were assessed at 30 days after treatment. Furthermore, at the 2-year follow-up, the estimated outcomes of primary patency, primary-assisted patency, secondary patency, and limb salvage were analyzed with Kaplan-Meier curves and compared between groups with the log-rank test.
RESULTS: Both groups were homogeneous in terms of demographic data, preoperative risk factors, and clinical presentation. However, compared with DN group, more patients in PE group had a great saphenous vein diameter of less than 3 mm (11.1% vs 21%; P = .007). Intraoperatively, both groups showed similar distal anastomosis sites: below-the-knee popliteal artery (63% DN group, 66.4% PE group) and tibial vessel (37% DN group, 33.6% PE group) (P = .3). The overall mean duration of follow-up was 11.6 months (range, 1-24 months). At the 2-year follow-up, there were no differences between the two groups in terms of primary patency (66.3% DN group vs 74.1% PE group; P = .9), primary-assisted patency (78.2% DN group vs 79.5% PE group; P = .2), secondary patency (85.1% DN group vs 91.4% PE group; P = .2), and limb salvage (95.2% DN group vs 95.1% PE group; P = .9).
CONCLUSIONS: The LIMBSAVE registry did not show a worsening of overall patency and limb salvages rates at the 2-year follow-up in patients undergoing in situ saphenous bypass after a failed endovascular approach for long femoropopliteal occlusive disease. This finding is in contrast with what has been published in literature.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:76 |
---|---|
Enthalten in: |
Journal of vascular surgery - 76(2022), 3 vom: 01. Sept., Seite 797-805 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Troisi, Nicola [VerfasserIn] |
---|
Links: |
---|
Themen: |
Critical limb-threatening ischemia |
---|
Anmerkungen: |
Date Completed 24.08.2022 Date Revised 25.09.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jvs.2022.03.884 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM340849037 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM340849037 | ||
003 | DE-627 | ||
005 | 20231226010416.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jvs.2022.03.884 |2 doi | |
028 | 5 | 2 | |a pubmed24n1136.xml |
035 | |a (DE-627)NLM340849037 | ||
035 | |a (NLM)35561942 | ||
035 | |a (PII)S0741-5214(22)01500-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Troisi, Nicola |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comparison of long occlusive femoropopliteal de novo versus previous endovascularly treated lesions managed with in situ saphenous bypass |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.08.2022 | ||
500 | |a Date Revised 25.09.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved. | ||
520 | |a BACKGROUND: The aim of this study was to compare the 2-year outcomes of de novo versus postendovascular lesion treatment of femoropopliteal occlusions included in a national, multicenter, observational, prospective registry based on the treatment of critical Limb-threatening IschaeMia with infragenicular Bypass adopting in situ SAphenous VEin technique (LIMBSAVE) registry | ||
520 | |a METHODS: From January 2018 to December 2019, 541 patients from 43 centers have been enrolled in the LIMBSAVE registry. Of these patients, 460 were included in the present study: 341 (74.1%) with de novo lesions (DN group) and 119 (25.9%) with postendovascular treatment lesions (PE group). Initial outcome measures were assessed at 30 days after treatment. Furthermore, at the 2-year follow-up, the estimated outcomes of primary patency, primary-assisted patency, secondary patency, and limb salvage were analyzed with Kaplan-Meier curves and compared between groups with the log-rank test | ||
520 | |a RESULTS: Both groups were homogeneous in terms of demographic data, preoperative risk factors, and clinical presentation. However, compared with DN group, more patients in PE group had a great saphenous vein diameter of less than 3 mm (11.1% vs 21%; P = .007). Intraoperatively, both groups showed similar distal anastomosis sites: below-the-knee popliteal artery (63% DN group, 66.4% PE group) and tibial vessel (37% DN group, 33.6% PE group) (P = .3). The overall mean duration of follow-up was 11.6 months (range, 1-24 months). At the 2-year follow-up, there were no differences between the two groups in terms of primary patency (66.3% DN group vs 74.1% PE group; P = .9), primary-assisted patency (78.2% DN group vs 79.5% PE group; P = .2), secondary patency (85.1% DN group vs 91.4% PE group; P = .2), and limb salvage (95.2% DN group vs 95.1% PE group; P = .9) | ||
520 | |a CONCLUSIONS: The LIMBSAVE registry did not show a worsening of overall patency and limb salvages rates at the 2-year follow-up in patients undergoing in situ saphenous bypass after a failed endovascular approach for long femoropopliteal occlusive disease. This finding is in contrast with what has been published in literature | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Observational Study | |
650 | 4 | |a Critical limb-threatening ischemia | |
650 | 4 | |a In situ saphenous vein | |
650 | 4 | |a Limb salvage | |
650 | 4 | |a Peripheral bypass | |
700 | 1 | |a Michelagnoli, Stefano |e verfasserin |4 aut | |
700 | 1 | |a Adami, Daniele |e verfasserin |4 aut | |
700 | 1 | |a Berchiolli, Raffaella |e verfasserin |4 aut | |
700 | 0 | |a LIMBSAVE registry Collaborative Group |e verfasserin |4 aut | |
700 | 1 | |a Accrocca, Federico |e investigator |4 oth | |
700 | 1 | |a Amico, Alessio |e investigator |4 oth | |
700 | 1 | |a Angelini, Andrea |e investigator |4 oth | |
700 | 1 | |a Arnuzzo, Luca |e investigator |4 oth | |
700 | 1 | |a Marchetti, Andrea Ascoli |e investigator |4 oth | |
700 | 1 | |a Attisani, Luca |e investigator |4 oth | |
700 | 1 | |a Bafile, Gennaro |e investigator |4 oth | |
700 | 1 | |a Baldino, Giuseppe |e investigator |4 oth | |
700 | 1 | |a Barbanti, Enrico |e investigator |4 oth | |
700 | 1 | |a Bartoli, Stefano |e investigator |4 oth | |
700 | 1 | |a Bellosta, Raffaello |e investigator |4 oth | |
700 | 1 | |a Benedetto, Filippo |e investigator |4 oth | |
700 | 1 | |a Borioni, Raoul |e investigator |4 oth | |
700 | 1 | |a Briolini, Franco |e investigator |4 oth | |
700 | 1 | |a Busoni, Cristina |e investigator |4 oth | |
700 | 1 | |a Camparini, Stefano |e investigator |4 oth | |
700 | 1 | |a Cappiello, Pierluigi |e investigator |4 oth | |
700 | 1 | |a Carbonari, Luciano |e investigator |4 oth | |
700 | 1 | |a Casella, Francesco |e investigator |4 oth | |
700 | 1 | |a Celoria, Giovanni |e investigator |4 oth | |
700 | 1 | |a Chiama, Andrea |e investigator |4 oth | |
700 | 1 | |a Chisci, Emiliano |e investigator |4 oth | |
700 | 1 | |a Civilini, Efrem |e investigator |4 oth | |
700 | 1 | |a Codispoti, Francesco |e investigator |4 oth | |
700 | 1 | |a Conti, Barbara |e investigator |4 oth | |
700 | 1 | |a Coppi, Giovanni |e investigator |4 oth | |
700 | 1 | |a De Blasis, Giovanni |e investigator |4 oth | |
700 | 1 | |a D'Elia, Marcello |e investigator |4 oth | |
700 | 1 | |a Di Domenico, Rossella |e investigator |4 oth | |
700 | 1 | |a Di Girolamo, Carla |e investigator |4 oth | |
700 | 1 | |a Ercolini, Leonardo |e investigator |4 oth | |
700 | 1 | |a Ferrari, Alessandra |e investigator |4 oth | |
700 | 1 | |a Ferrari, Mauro |e investigator |4 oth | |
700 | 1 | |a Forliti, Enzo |e investigator |4 oth | |
700 | 1 | |a Frigatti, Paolo |e investigator |4 oth | |
700 | 1 | |a Frigerio, Dalmazio |e investigator |4 oth | |
700 | 1 | |a Frosini, Pierfrancesco |e investigator |4 oth | |
700 | 1 | |a Garriboli, Luca |e investigator |4 oth | |
700 | 1 | |a Giordano, Antonio Nicola |e investigator |4 oth | |
700 | 1 | |a Guerrieri, Walter |e investigator |4 oth | |
700 | 1 | |a Jannello, Antonio |e investigator |4 oth | |
700 | 1 | |a Massara, Mafalda |e investigator |4 oth | |
700 | 1 | |a Merlo, Maurizio |e investigator |4 oth | |
700 | 1 | |a Mezzetti, Roberto |e investigator |4 oth | |
700 | 1 | |a Miccoli, Tommaso |e investigator |4 oth | |
700 | 1 | |a Milite, Domenico |e investigator |4 oth | |
700 | 1 | |a Mingazzini, Pietro |e investigator |4 oth | |
700 | 1 | |a Muncinelli, Marina |e investigator |4 oth | |
700 | 1 | |a Nano, Giovanni |e investigator |4 oth | |
700 | 1 | |a Natola, Marco |e investigator |4 oth | |
700 | 1 | |a Novali, Claudio |e investigator |4 oth | |
700 | 1 | |a Palasciano, Giancarlo |e investigator |4 oth | |
700 | 1 | |a Perkmann, Reinhold |e investigator |4 oth | |
700 | 1 | |a Persi, Federica |e investigator |4 oth | |
700 | 1 | |a Petruccelli, David |e investigator |4 oth | |
700 | 1 | |a Pinelli, Mauro |e investigator |4 oth | |
700 | 1 | |a Poletto, Giorgio |e investigator |4 oth | |
700 | 1 | |a Porta, Carla |e investigator |4 oth | |
700 | 1 | |a Pratesi, Carlo |e investigator |4 oth | |
700 | 1 | |a Pruner, Gianguido |e investigator |4 oth | |
700 | 1 | |a Ragazzi, Giovanni |e investigator |4 oth | |
700 | 1 | |a Righini, Paolo |e investigator |4 oth | |
700 | 1 | |a Salvini, Mauro |e investigator |4 oth | |
700 | 1 | |a Scovazzi, Paolo |e investigator |4 oth | |
700 | 1 | |a Setacci, Carlo |e investigator |4 oth | |
700 | 1 | |a Settembrini, Alberto Maria |e investigator |4 oth | |
700 | 1 | |a Siani, Andrea |e investigator |4 oth | |
700 | 1 | |a Silingardi, Roberto |e investigator |4 oth | |
700 | 1 | |a Silvestro, Antonino |e investigator |4 oth | |
700 | 1 | |a Talarico, Francesco |e investigator |4 oth | |
700 | 1 | |a Tolva, Valerio |e investigator |4 oth | |
700 | 1 | |a Trani, Antonio |e investigator |4 oth | |
700 | 1 | |a Trimarchi, Santi |e investigator |4 oth | |
700 | 1 | |a Tshomba, Yamume |e investigator |4 oth | |
700 | 1 | |a Vigliotti, Gennaro |e investigator |4 oth | |
700 | 1 | |a Viola, Daniela |e investigator |4 oth | |
700 | 1 | |a Volpe, Pietro |e investigator |4 oth | |
700 | 1 | |a Zani, Federico |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Journal of vascular surgery |d 1988 |g 76(2022), 3 vom: 01. Sept., Seite 797-805 |w (DE-627)NLM012713147 |x 1097-6809 |7 nnns |
773 | 1 | 8 | |g volume:76 |g year:2022 |g number:3 |g day:01 |g month:09 |g pages:797-805 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jvs.2022.03.884 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 76 |j 2022 |e 3 |b 01 |c 09 |h 797-805 |